Stephen Basso
Financieel Directeur/CFO bij INNOVIVA, INC.
Actieve functies van Stephen Basso
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INNOVIVA, INC. | Financieel Directeur/CFO | 21-08-2023 | - |
Loopbaan van Stephen Basso
Eerdere bekende functies van Stephen Basso
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INOZYME PHARMA, INC. | Comptroller/Controller/Auditor | 01-10-2017 | 14-05-2021 |
| Financieel Directeur/CFO | 01-10-2017 | 14-05-2021 | |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2009 | 01-05-2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Operationeel Directeur | - | - |
| Financieel Directeur/CFO | - | - |
Opleiding van Stephen Basso
| Boston College | Masters Business Admin |
| Providence College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Health Technology |
- Beurs
- Insiders
- Stephen Basso
- Ervaring